Renaissance Technologies - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$23,934,000
-0.8%
7,598,131
-8.4%
0.02%
+14.3%
Q2 2020$24,136,000
+4.1%
8,294,249
+0.9%
0.02%
-8.7%
Q1 2020$23,190,000
-12.5%
8,223,531
+0.6%
0.02%
+15.0%
Q4 2019$26,514,000
+31.1%
8,170,631
-12.7%
0.02%
+17.6%
Q3 2019$20,227,000
-28.6%
9,364,285
+3.8%
0.02%
-32.0%
Q2 2019$28,326,000
-20.9%
9,021,082
-6.3%
0.02%
-24.2%
Q1 2019$35,818,000
+36.1%
9,628,500
+6.1%
0.03%
+13.8%
Q4 2018$26,319,000
+9.1%
9,075,500
-1.1%
0.03%
+16.0%
Q3 2018$24,127,000
-52.7%
9,173,954
-52.6%
0.02%
-10.7%
Q2 2018$51,039,000
+79.9%
19,337,208
+100.4%
0.03%
-9.7%
Q1 2018$28,368,000
+0.7%
9,648,854
-6.2%
0.03%0.0%
Q4 2017$28,179,000
-25.3%
10,284,454
-7.6%
0.03%
-29.5%
Q3 2017$37,737,000
+42.7%
11,131,786
+4.0%
0.04%
+29.4%
Q2 2017$26,440,000
-3.2%
10,704,400
-11.1%
0.03%
-10.5%
Q1 2017$27,323,000
+0.1%
12,036,754
-6.5%
0.04%
-11.6%
Q4 2016$27,296,000
-39.5%
12,875,700
-4.4%
0.04%
-46.2%
Q3 2016$45,134,000
+14.4%
13,472,854
+7.2%
0.08%
+6.7%
Q2 2016$39,456,000
-6.9%
12,565,654
-1.2%
0.08%
-7.4%
Q1 2016$42,372,000
+15.7%
12,724,354
+23.0%
0.08%
+1.2%
Q4 2015$36,623,000
-19.1%
10,345,559
+15.0%
0.08%
-25.9%
Q3 2015$45,251,000
-39.0%
8,996,154
-22.0%
0.11%
-36.1%
Q2 2015$74,156,000
-11.9%
11,532,754
-3.7%
0.17%
-5.6%
Q1 2015$84,220,000
-7.2%
11,971,554
+1.7%
0.18%
-18.3%
Q4 2014$90,754,000
-11.6%
11,771,000
-14.4%
0.22%
-22.1%
Q3 2014$102,682,000
-17.7%
13,745,892
+6.6%
0.28%
-3.4%
Q2 2014$124,841,000
+26.7%
12,896,754
+8.7%
0.29%
+23.3%
Q1 2014$98,550,000
+0.1%
11,859,184
+1.7%
0.24%0.0%
Q4 2013$98,456,000
+6.6%
11,665,354
+0.6%
0.24%
+5.4%
Q3 2013$92,388,000
-0.2%
11,591,954
-3.3%
0.22%
-7.8%
Q2 2013$92,552,00011,988,5540.24%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders